January 2021 Archives by thread

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...

Starting: Sat Jan 2 03:24:00 PST 2021
Ending: Sat Jan 30 11:21:35 PST 2021
Messages: 50

• [Ip-health] The Delhi high court on Thursday restrained Sci Hub and Libgen, two online repositories providing free access to paywalled research   leena menghaney
• [Ip-health] Russian Government Grants Compulsory License for Remdevisir   James Love
• [Ip-health] GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration   Katy Athersuch
• [Ip-health] Last call for applications: MPP looking for two new Board Members   Sophie Thievenaz
• [Ip-health] NIST requests comment on proposal to weaken march-in rights   Zain Rizvi
• [Ip-health] Politico: MEP Canfin to Commission: We need more details on CureVac vaccine contract   Thiru Balasubramaniam
• [Ip-health] WHO informal consultation (3 December 2020) addressed concerns on price transparency and shortages   Thiru Balasubramaniam
• [Ip-health] New South Centre Paper: Reconsidérations sur la fabrication mondiale et locale de produits médicaux après le COVID-19   Anna Bernardo
• [Ip-health] MSF blog: will history repeat itself? rebutting pharma's rejection of a global COVID-19 IP waiver   Yuanqiong HU
• [Ip-health] RIS Webinar on19th Jan-Innovation and Access in Vaccines, and Health Impact Fund   ravi srinivas
• [Ip-health] RIS Webinar on 19th 6.30 PM IST Innovation & Access in Vaccines, & Health Impact Fund   ravi srinivas
• [Ip-health] HAI statement at EB148 14.1 WHO Covid-19 response   Jaume Vidal
• [Ip-health] WHO EB 148: Oral statement of Knowledge Ecology International on the COVID-19 response   Thiru Balasubramaniam
• [Ip-health] Online discussion of NIST proposals to change Bayh-Dole regulations and statutes – January 27, 2021 at 2PM   Claire Cassedy
• [Ip-health] EB 148: WHO’s COVID-19 Technology Access Pool (C-TAP) comes under scrutiny   Thiru Balasubramaniam
• [Ip-health] NEW South Centre Policy Brief: Repenser la R&D pour les produits pharmaceutiques après le choc du nouveau coronavirus COVID-19   Anna Bernardo
• [Ip-health] The USA rejoins the WHO, plans to join COVAX and support the ACT-Accelerator   Susan Isiko Strba
• [Ip-health] Letter from the People’s Vaccine Alliance and Health Action International to Dr. Tedros on C-TAP   Thiru Balasubramaniam
• [Ip-health] Statement: Biden, go bigger on COVID-19 vaccines   Peter Maybarduk
• [Ip-health] The European Commission-Curevac Advance Purchase Contract for a COVID-19 Vaccine   Claire Cassedy
• [Ip-health] ONE welcomes calls for suspension of patents on COVID vaccines   Claire Cassedy
• [Ip-health] The Guardian: WHO platform for pharmaceutical firms unused since pandemic began   Thiru Balasubramaniam
• [Ip-health] HAI statement at EB148 7 Expanding access to effective treatments for cancer and rare and orphan diseases, including medicines, vaccines, medical devices   Jaume Vidal
• [Ip-health] HAI statement at EB148 8 Global strategy and plan of action on public health, innovation and intellectual property   Jaume Vidal
• [Ip-health] TWN Info: COVID-19: Global “moral failure” in distribution of vaccines, says WHO DG   Sangeeta Shashikant
• [Ip-health] TWN Info: Opponents of TRIPS waiver asked to respond to questions by proponents   Sangeeta Shashikant
• [Ip-health] TRIPS Waiver update at WTO   Priti Patnaik
• [Ip-health] WHO EB 148: KEI’s statement on expanding access to effective treatments for cancer and rare and orphan diseases including cell and gene-based therapies   Thiru Balasubramaniam
• [Ip-health] EB 148: KEI’s statement on WHO’s Global Observatory on Health R&D   Thiru Balasubramaniam
• [Ip-health] EB 148: China and the United Kingdom raise concerns over the WHO Foundation and other WHO initiatives   Thiru Balasubramaniam
• [Ip-health] Webinar 26 January: Vaccine democracy and the role of local civil societies   Heesob Nam
• [Ip-health] The Lancet: CEPI Criticised for Lack of Transparency   Peter Maybarduk
• [Ip-health] TWN Info: Proponents of TRIPS waiver call for text-based negotiations   Sangeeta Shashikant
• [Ip-health] The Guardian: EU threatens to block Covid vaccine exports amid AstraZeneca shortfall   Thiru Balasubramaniam
  • [Ip-health] The Guardian: EU threatens to block Covid vaccine exports amid AstraZeneca shortfall   Chee Yoke Ling
• [Ip-health] Wed discuss of proposed changes in Bayh-Dole Act regulations and Stevenson-Wydler Act statutes   James Love
• [Ip-health] Agenda: Jan 27, 2020 Discussion of proposals to change Bayh-Dole regulations and Stevenson-Wydler Act statutes   James Love
• [Ip-health] Politico: Europe faces identity crisis over vaccine trade war - Free-trading Eurocrats want to avoid protectionism but are facing strong political headwinds.   Thiru Balasubramaniam
• [Ip-health] NEW South Centre Investment Policy Brief: Countries’ Policy Space to Implement Tobacco Packaging Measures: Revisiting the Philip Morris v. Uruguay Case   Anna Bernardo
• [Ip-health] Politico: How Europe fell behind on vaccines The EU secured some of the lowest prices in the world. At what cost? (Long read)   Thiru Balasubramaniam
• [Ip-health] Moderna Contract Modifications for Extra Doses Obtained by KEI Through Lawsuit   Claire Cassedy
  • [Ip-health] Moderna Contract Modifications for Extra Doses Obtained by KEI Through Lawsuit   Julia Barnes-Weise
• [Ip-health] Howard Dean: 'March In' is Not the Answer | Opinion   James Love
• [Ip-health] COVID-19: Vaccines war underscores need for TRIPS waiver at WTO   Sangeeta Shashikant
• [Ip-health] Winnie Byanyima in The Guardian: A global vaccine apartheid is unfolding. People’s lives must come before profit   Thiru Balasubramaniam
• [Ip-health] Politico: EU brandishes export ban to claim dibs on vaccines - After production setbacks by Pfizer and AstraZeneca, Commission announces measures to block international shipments.   Thiru Balasubramaniam
• [Ip-health] Law360: Feds Can't Dodge Gilead HIV Patent Counterclaims   Thiru Balasubramaniam
• [Ip-health] TWN Info: “Global approach” based on TRIPS waiver needed to combat Covid-19   Sangeeta Shashikant
• [Ip-health] Novavax and Inovio COVID-19 Vaccine Contracts Limit Prices Companies Can Charge for Their Products   kathryn ardizzone
• [Ip-health] New York Times: E.U. Makes a Sudden and Embarrassing U-Turn on Vaccines   Thiru Balasubramaniam

Last message date: Sat Jan 30 11:21:35 PST 2021
Archived on: Sat Jan 30 11:23:04 PST 2021

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...